Qube Research & Technologies Ltd
Position in SNDX — Syndax Pharmaceuticals Inc
CIK 1729829
LONDON, X0
Position in SNDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,431,198
+$9,589,141 QoQ
Shares Held
477,182
+1223.8% QoQ
Ownership
0.534%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#46
of 242 holders
Holding Since
Jun 2020
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SNDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Qube Research & Technologies Ltd holds $2,443,042,063 across 169 Biotechnology names. SNDX ranks #46 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
798,715 | $240,437,176 | |
| 2 | INSM |
INSMED Inc
|
1,682,334 | $179,370,451 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
221,607 | $138,180,828 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
3,454,496 | $122,254,613 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
426,336 | $104,354,262 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
659,678 | $87,559,060 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,443,230 | $81,989,896 | |
| 8 | RPRX |
Royalty Pharma plc
|
1,412,112 | $79,177,119 |
All Filings in SNDX
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,431,198 | 477,182 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $842,057 | 36,047 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $14,457,758 | 688,137 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $25,305,924 | 1,644,844 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $15,601,303 | 1,665,916 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $10,256,119 | 834,849 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $9,576,779 | 724,416 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $13,151,638 | 683,202 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $6,103,630 | 297,303 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,234,558 | 93,889 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,239,571 | 57,361 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,996,840 | 206,394 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,736,764 | 130,758 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $857,704 | 40,611 | Shares | Sole | 2023-05-15 | |
| 2022-03-31 | $731,228 | 42,073 | Shares | Sole | 2022-05-09 | |
| 2020-06-30 | $309,026 | 20,852 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||